Convergent Evolution of Escape from Hepaciviral Antagonism in Primates
Open accessThe DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
The ability to mount an interferon response on sensing viral infection is a critical component of mammalian innate immunity. Several viruses directly antagonize viral sensing pathways to block activation of the host immune response. Here, we show that recurrent viral antagonism has shaped the evolution of the host protein MAVS--a crucial component of the viral-sensing pathway in primates. From sequencing and phylogenetic analyses of MAVS from 21 simian primates, we found that MAVS has evolved under strong positive selection. We focused on how this positive selection has shaped MAVS' susceptibility to Hepatitis C virus (HCV). We functionally tested MAVS proteins from diverse primate species for their ability to resist antagonism by HCV, which uses its protease NS3/4A to cleave human MAVS. We found that MAVS from multiple primates are resistant to inhibition by the HCV protease. This resistance maps to single changes within the protease cleavage site in MAVS, which protect MAVS from getting cleaved by the HCV protease. Remarkably, most of these changes have been independently acquired at a single residue 506 that evolved under positive selection. We show that "escape" mutations lower affinity of the NS3 protease for MAVS and allow it to better restrict HCV replication. We further show that NS3 proteases from all other primate hepaciviruses, including the highly divergent GBV-A and GBV-C viruses, are functionally similar to HCV. We conclude that convergent evolution at residue 506 in multiple primates has resulted in escape from antagonism by hepaciviruses. Our study provides a model whereby insights into the ancient history of viral infections in primates can be gained using extant host and virus genes. Our analyses also provide a means by which primates might clear infections by extant hepaciviruses like HCV.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 MAVS has evolved under positive selection in primates. (A) dN/dS ratios for the MAVS gene, calculated using free-ratio model in PAML, are shown on a phylogeny [26] along with common and scientific names of the primate species represented. Branches with dN/dS ratios greater than 1 are highlighted in red. For branches that did not experience any synonymous (S) changes, number of nonsynonymous (N) and S changes are shown in parentheses. (B) Residues identified as being under recurrent positive selection are indicated on a schematic of the MAVS protein, including the CARD, Proline-rich, and transmembrane (TM) domains. CodeML program of PAML software was used to identify sites under positive selection by comparing M7 (beta) versus M8 (beta & ω) models, assuming codon frequencies according to the F61 model. Web-based implementation of HyPhy package was used to perform REL analysis. We present only those sites identified with a posterior probability higher than 0.9 in both Bayes empirical Bayes (BEB) and random effects likelihood (REL) methods.](https://figures.cochat.ai/paper-figures/a92e7577dd1343f8a439fc331bfa2462/convergent-evolution-of-escape-from-hepaciviral-antagonism-in-primates-figure-1.jpg)



![Figure 5 NS3 proteases from distantly related GB viruses inhibit human MAVS. (A) Phylogram made using NS3 sequence from the indicated viruses. Bootstrap values are indicated for each branch. Scale represents 0.1 amino acid substitutions per site. Bovine viral diarrheal virus (BVDV) and Yellow fever virus (YFV) are representative pesti- and flaviviruses, respectively. We refer to GBV-C and GBV-A viruses as hepaciviruses, although they have not been formally assigned to a particular genus within the Flaviviridae family. GBV-C is also known as Hepatitis G virus (HGV). CHV stands for canine hepacivirus [17]. Corresponding hosts that can be naturally infected by each virus are indicated on the right. (B) IFN-β induction, as determined by luciferase firefly activity upon expression of human MAVS in the presence of NS3 protease from the corresponding virus in (A). IFN-β induction is normalized as being 100% in absence of any protease. Experiments were performed in triplicate with error bars indicating standard deviation.](https://figures.cochat.ai/paper-figures/7ee3f99151af48d6be3a639ae7eb297b/convergent-evolution-of-escape-from-hepaciviral-antagonism-in-primates-figure-5.jpg)


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Several core components of the vertebrate immune system have subsequently been shown to engage in such conflicts, some of which are able to dictate the outcome of an infection 29, 30, 31, 32, 33, 34, 35.”
From Buried Treasure: Evolutionary Perspectives on Microbial Iron Piracy (2015) · cites this paper as [33]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PAML 4: Phylogenetic Analysis by Maximum Likelihood
Yang, Z. (2007) · Molecular Biology and Evolution · doi:10.1093/molbev/msm088 · Cited by 13,879 · cited 8×
“However, using maximum-likelihood analyses [27,28], we found that MAVS has evolved under strong positive selection in primates.”
BackgroundMethodInfluentialPAML: a program package for phylogenetic analysis by maximum likelihood
Yang, Z. (1997) · Bioinformatics · doi:10.1093/bioinformatics/13.5.555 · Cited by 5,373 · cited 8×
“However, using maximum-likelihood analyses [27,28], we found that MAVS has evolved under strong positive selection in primates.”
BackgroundMethodInfluentialThe HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
Gerold, G., & Pietschmann, T. (2014) · Digestive Diseases · doi:10.1159/000360830 · Cited by 4,854
Yoneyama, M., Kikuchi, M., Natsukawa, T., Shinobu, N., Imaizumi, T., Miyagishi, M., Taira, K., Akira, S., & Fujita, T. (2004) · Nature Immunology · doi:10.1038/ni1087 · Cited by 3,929 · cited 1×
“Among the myriad of antiviral mechanisms employed by mammalian cells, the ability to sense viral RNA has emerged as a critical component of innate immunity. Viral RNA is detected in the cytoplasm by sensor proteins RIG-I and MDA-5”
BackgroundGenetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
Ge, D., Fellay, J., Thompson, A. J., Simon, J. S., Shianna, K. V., Urban, T. J., Heinzen, E. L., Qiu, P., Bertelsen, A. H., Muir, A. J., et al. (2009) · Nature · doi:10.1038/nature08309 · Cited by 3,514 · cited 1×
“Furthermore, a polymorphism near a type III interferon gene is associated with spontaneous and treatment-induced clearance of HCV [45,46].”
BackgroundSeth, R. B., Sun, L., Ea, C.-K., & Chen, Z. J. (2005) · Cell · doi:10.1016/j.cell.2005.08.012 · Cited by 3,329
IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction
Kawai, T., Takahashi, K., Sato, S., Coban, C., Kumar, H., Kato, H., Ishii, K. J., Takeuchi, O., & Akira, S. (2005) · Nature Immunology · doi:10.1038/ni1243 · Cited by 2,562 · cited 3×
“Viral RNA is detected in the cytoplasm by sensor proteins RIG-I and MDA-5 [1–3].”
BackgroundCardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus
Meylan, E., Curran, J., Hofmann, K., Moradpour, D., Binder, M., Bartenschlager, R., & Tschopp, J. (2005) · Nature · doi:10.1038/nature04193 · Cited by 2,401 · cited 1×
“In particular, several viruses encode antagonists of MAVS function”
BackgroundGenetic variation in IL28B and spontaneous clearance of hepatitis C virus
Thomas, D. L., Thio, C. L., Martin, M. P., Qi, Y., Ge, D., O’hUigin, C., Kidd, J., Kidd, K., Khakoo, S. I., Alexander, G., et al. (2009) · Nature · doi:10.1038/nature08463 · Cited by 2,150 · cited 1×
“HCV cleaves MAVS in order to block the interferon response. The importance of this strategy employed by HCV is highlighted by the fact that interferon treatment is often clinically used to successfully cure HCV infection. Furthermore, a polymorphism near a type III interferon gene is associated with spontaneous and tr…”
BackgroundVISA Is an Adapter Protein Required for Virus-Triggered IFN-β Signaling
Xu, L.-G., Wang, Y.-Y., Han, K.-J., Li, L.-Y., Zhai, Z., & Shu, H.-B. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.08.014 · Cited by 1,853 · cited 1×
“MAVS pathway in Figure S1) [4–7].”
Research works printed but not linked: 1
- Fields B. N Knipe D. M Howley P. M 2007 Fields' virology Philadelphia Wolters Kluwer Health/Lippincott Williams & Wilkins 2 v. (xix, 3091, 3086 pp.)
Cited by
Decoding type I and III interferon signalling during viral infection
Mesev, E. V., LeDesma, R. A., & Ploss, A. (2019) · Nature Microbiology · doi:10.1038/s41564-019-0421-x · Cited by 538
Rules of engagement: molecular insights from host–virus arms races
Daugherty, M. D., & Malik, H. S. (2012) · Annual Review of Genetics · doi:10.1146/annurev-genet-110711-155522 · Cited by 515
Self-citationYi, C., Sun, X., Ye, J., Ding, L., Liu, M., Yang, Z., Lu, X., Zhang, Y., Ma, L., Gu, W., et al. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-0458-z · Cited by 486
Genome of the Chinese tree shrew
Fan, Y., Huang, Z.-Y., Cao, C.-C., Chen, C.-S., Chen, Y.-X., Fan, D.-D., He, J., Hou, H.-L., Hu, L., Hu, X.-T., et al. (2013) · Nature Communications · doi:10.1038/ncomms2416 · Cited by 364
“3), in which recurrent viral antagonism has led to a convergent evolution of escape from hepaciviral antagonism in primates 42 .”
Bats are a major natural reservoir for hepaciviruses and pegiviruses
Quan, P.-L., Firth, C., Conte, J. M., Williams, S. H., Zambrana-Torrelio, C. M., Anthony, S. J., Ellison, J. A., Gilbert, A. T., Kuzmin, I. V., Niezgoda, M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1303037110 · Cited by 285
Metadata
- Authors
- Patel, M. R., Loo, Y.-M., Horner, S. M., Gale, M., & Malik, H. S.
- Affiliations
- Fred Hutch Cancer Center (US)
- University of Washington (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Malik, Harmit S.
- Venue
- PLoS Biology
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-03-13
- Volume
- 10
- Issue
- 3
- Pages
- e1001282
- ISSN
- 1544-9173 (ISSN-L)
- 1545-7885
- PMC
- PMC3302847
- OpenAlex
- W2120167579
- Cited by
- 95
- References
- 53
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 2 · 2023: 4 · 2022: 6 · 2021: 7 · 2020: 7 · 2019: 5 · 2018: 8 · 2017: 7 · 2016: 4 · 2015: 11 · 2014: 6 · 2013: 16 · 2012: 8
- FWCI
- 5.73
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Biology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- National Science Foundation (CAREER)
- Howard Hughes Medical Institute
- Cancer Research Institute
- National Institutes of Health (AI083019, AI88778, AI060389)
- National Cancer Institute (P30CA015704)
- National Institute of Allergy and Infectious Diseases (R01AI060389, U19AI083019, AI88778, R56AI060389, AI-060389, AI083019, U19AI088778)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Health Sciences › Medicine › Hepatology › Hepatitis C virus research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Evolution and Genetic Dynamics
- Keywords
- MAVS, interferon response, viral antagonism, hepatitis C virus, NS3/4A protease, hepatitis G virus, positive selection, convergent evolution, viral sensing, host-virus coevolution, proteolytic cleavage sites
- MeSH terms
- Viral Proteases, Amino Acid Sequence, Animals, Genes, Viral, Hepatitis C, Humans, Models, Molecular, Molecular Sequence Data, Phylogeny, Primates, Selection, Genetic, Serine Endopeptidases, Virus Replication, Hepacivirus, Sequence Alignment, Viral Nonstructural Proteins, Evolution, Molecular, Nucleoside-Triphosphatase, Adaptor Proteins, Signal Transducing, DEAD-box RNA Helicases, Host-Pathogen Interactions, Proteolysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.